2 news items
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
KPTI
8 May 24
.Gastrointestinal Toxicity: Nausea, vomiting, diarrhea, anorexia, and weight loss may
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
KPTI
24 Apr 24
.Gastrointestinal Toxicity: Nausea, vomiting
- Prev
- 1
- Next